A quantitative, multi-national and multi-stakeholder assessment of barriers to the adoption of cell therapies. (2017)
Attributed to:
RegenVOX: phase I/II clinical trial of stem cell based tissue engineered laryngeal implants
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1177/2041731417724413
PubMed Identifier: 28835816
Publication URI: http://europepmc.org/abstract/MED/28835816
Type: Journal Article/Review
Volume: 8
Parent Publication: Journal of tissue engineering
ISSN: 2041-7314